alexa RECENT AND ADVANCED THERAPEUTIC AND DIAGNOSTIC STRATEGIES FOR TYPE 2 DIABETES AND GENE THERAPY APPROACH AS ULTIMATE TYPE 2 DIABETES TREATMENTPAMELA GEORGINA AVILA LAMADRID
ISSN: 2167-0943

Journal of Metabolic Syndrome
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Metabolic Syndrome
August 10-11, 2017 | London, UK

Rasoul Salehi, Ahmad Raza Salehi, Moosa Rahimi, Nasimeh Vatandoust and Sedigheh Momenzadeh
Isfahan University of Medical Sciences, Iran
Posters & Accepted Abstracts: J Metabolic Synd
DOI: 10.4172/2167-0943-C1-006
Abstract
It has now become obvious that the pathophysiological defects leading to type 2 diabetes (T2D) is much more complex than thought before. Insulin resistance is an early event in the course of T2D development. The transition from normoglycemy to prediabetes is usually a gradual phenomenon that occurs over 5-10 years during which the disease remains undetected. Among the routinely practiced T2D screening criteria, like FPG, IFG, IGT or HbA1c, still the issue of a preferable one is debated. Here I present more precise non-invasive presymptomatic diagnosis and risk assessment strategies including noncoding RNAs signature in peripheral blood. Life style changes with addition of metformin, sulphonylureas, glinides, α-glucosidase inhibitors, thiazolidinediones and/or exogenous insulin are recommended as the present treatment options. These treatments offer improvement in glycemic control, but in many instances produce significant adverse side effects. Various novel incretin-based therapies like prolonging GLP-1 receptor agonists action, orally GLP-1 receptor agonists, GLP-1 secretion by activating GLP-1-producing intestinal L-cells, synthetic engineered peptides as co-agonists stimulating more than one receptor, etc. are discussed here. I also present our experiences regarding development of successful gene therapy using intestinal K-cells which are specialized for GIP production. Engineering these cells to produce insulin in response to the ingested carbohydrates successfully achieved. Oral gene delivery to these cells using nanoparticles with appropriate protective coats as well as plant exosomal gene delivery to the stem cell precursors of K-cells located at the base of intestinal crypts resulted in long lasting insulin expression by gut K-cells and pronounced treatment of T2D.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords